机构:[1]State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, Hong Kong, China[2]Department of Medicine, University of Hong Kong, Hong Kong, China[3]Department of Endocrinology, Jinling Hospital, Nanjing University, School of Medicine, Nanjing, China[4]School of Biomedical Sciences, Chinese University of Hong Kong, Hong Kong, China[5]State Key Laboratory of Stem Cell and Reproductive Biology, Chinese Academy of Sciences, Chaoyang District, Beijing, China[6]Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China[7]Department of Cardiology, The Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing, China江苏省人民医院[8]Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University, Nanjing, China[9]Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China[10]Clinical Department of Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China[11]State Key Laboratory of Animal Nutrition, Institute of Animal Science, Chinese Academy of Agricultural Sciences, Beijing, China[12]Department of Pharmacy and Pharmacology, University of Hong Kong, Hong Kong, China
第一作者机构:[1]State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, Hong Kong, China[2]Department of Medicine, University of Hong Kong, Hong Kong, China[3]Department of Endocrinology, Jinling Hospital, Nanjing University, School of Medicine, Nanjing, China
共同第一作者:
通讯作者:
通讯机构:[1]State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, Hong Kong, China[2]Department of Medicine, University of Hong Kong, Hong Kong, China[4]School of Biomedical Sciences, Chinese University of Hong Kong, Hong Kong, China[5]State Key Laboratory of Stem Cell and Reproductive Biology, Chinese Academy of Sciences, Chaoyang District, Beijing, China[6]Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China[12]Department of Pharmacy and Pharmacology, University of Hong Kong, Hong Kong, China
推荐引用方式(GB/T 7714):
Ping Gu,Xiaoyan Hui,Qiantao Zheng,et al.Mitochondrial uncoupling protein 1 antagonizes atherosclerosis by blocking NLRP3 inflammasome-dependent interleukin-1β production.[J].Science advances.2021,7(50):eabl4024.doi:10.1126/sciadv.abl4024.
APA:
Ping Gu,Xiaoyan Hui,Qiantao Zheng,Yuan Gao,Leigang Jin...&Aimin Xu.(2021).Mitochondrial uncoupling protein 1 antagonizes atherosclerosis by blocking NLRP3 inflammasome-dependent interleukin-1β production..Science advances,7,(50)
MLA:
Ping Gu,et al."Mitochondrial uncoupling protein 1 antagonizes atherosclerosis by blocking NLRP3 inflammasome-dependent interleukin-1β production.".Science advances 7..50(2021):eabl4024